
Last updated: 2026-09-16 10:31:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Advanced Biomed Inc. (ADVB) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $8.15, with a market capitalisation of $12.85M and a P/E ratio of 2.53. Over the past 52 weeks, its price has ranged from $3.61 to $24.23. This page covers its latest market performance, valuation, price trends and company information.
$12.85M | |
$8.15 | |
$82.00 | |
$3.61 | |
$8.08 | |
64.00 | |
1.77M | |
2.53 | |
$24.23 | |
$3.61 | |
-- | |
-- |
Advanced Biomed Inc. (ADVB) is trading at $8.15 in pre-market trading as of 2026-09-16 08:02:00, up 0.87% ($0.07) from the previous close of $8.08
Pre-market trading shows how investors are pricing ADVB before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Advanced Biomed Inc. (ADVB) moved from $9.34 to $8.15, representing a decline of 12.69% ($1.19).
The stock traded between $7.41 and $9.44 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 63.38 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 22.0%
ADVB is currently trading at $8.15, placing it 22.0% of the way from its 52-week low of $3.61 to its 52-week high of $24.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 31 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Advanced Biomed Inc. (ADVB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.